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Redox Biology, 
 
Dear Editor, 
  
:HZRXOGEHJUDWHIXOLI\RXZRXOGFRQVLGHURXUPDQXVFULSW³JNK signalling regulates antioxidant responses 
in neurons.´by Ugbode et al., for publication in Redox Biology. 
 
Reactive oxygen species (ROS) accumulation is a hallmark of ageing. It is also prevalent in 
QHXURGHJHQHUDWLYHFRQGLWLRQVLQFOXGLQJ$O]KHLPHU¶VDQG3DUNLQVRQ¶VGLVHDVH&ULWLFDOWRWKHGHYHORSPHQWRI
therapeutic strategies, is a basic understanding of how neurons sense and respond to ROS at both the 
physiological and pathophysiological level. This study builds on our previous work, which identified 
differential responses between synaptic activity (Oswald et al, 2018, eLife) and oxidative stress (Milton et al, 
2011, PNAS) in shaping neuronal plasticity, by identifying the mechanistic switch between physiology and 
stress: JNK signalling.  
 
During synaptic activity, neurons up-regulate their endogenous antioxidant response, a core component of 
which is SRXN1. This activity driven transcriptional response allows neurons to respond to synaptic inputs 
accordingly and maintain redox homeostasis. This system however is not perfect, and ROS can often 
accumulate which has potentially damaging effects. We have identified a way that neurons cope with this 
ROS imbalance and it centres on the well-known kinase, JNK.  
 
Unlike many papers, our work does not describe a simple JNK activation and cell death cascade. On the 
contrary, JNK activation during oxidative stress is protective. We found that this protection is because JNK 
regulates neuronal antioxidant responses. We show this first using two different Drosophila mutants that 
have enhanced JNK activity. This increase in JNK activity lowers ROS levels in the fly and renders them 
resistant to chemically LQGXFHGR[LGDWLYHVWUHVV)XUWKHUPRUHEORFNLQJXSVWUHDPUHJXODWRUVRI-1.DQGLW¶V
downstream effectors (AP-1) increases ROS levels in wild-type flies. We then show that JNK regulates 
antioxidant responses in mammalian neurons, culminating in the production of SRXN1. 
 
We believe this work is of interest to the readers of Redox Biology, because it demonstrates that JNK 
activation in neurons positively regulates antioxidant responses, an observation that is conserved between 
mammals and Drosophila. Finally and most importantly, these observations explain why JNK inhibitors have 
had limited success in neurodegenerative conditions. Better understanding of cell-autonomous JNK 
signalling is needed before JNK inhibition can be considered a therapeutic strategy.  
 
For reviewers we suggest the following: Michael Coleman (University of Cambridge, mc469@cam.ac.uk) an 
expert on axon degeneration and neuronal signalling; Giles Hardingham (CDBS, University of Edinburgh, 
Giles.Hardingham@ed.ac.uk) an expert in this field whose research has broken new ground in this area. We 
also suggest Eleanor Coffee (University of Turku, eleanor.coffey@btk.fi) an expert on JNK regulation in 
neurons. Catherine Collins (University of Michigan, collinca@umich.edu) is an expert on the Drosophila 
highwire mutation and synaptic plasticity, Juan Bolanos (University of Salamanca, jbolanos@usal.es) and 
Elizabeth Veal (elizabeth.veal@ncl.ac.uk) who both have expertise in redox homeostasis in the CNS. 
 
Thank you for your consideration and we look forward to hearing from you.   
  
Yours sincerely,  
  
 Sean Sweeney PhD.   
&RYHU/HWWHU
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Abstract 
Reactive oxygen species (ROS) are generated during physiological bouts of synaptic 
activity and as a consequence of pathological conditions in the central nervous 
system. How neurons respond to and distinguish between ROS in these different 
contexts is currently unknown. In Drosophila mutants with enhanced JNK activity, 
lower levels of ROS are observed and these animals are resistant to both changes in 
ROS and changes in synapse morphology induced by oxidative stress. In wild type 
flies, disrupting JNK-AP-1 signalling perturbs redox homeostasis suggesting JNK 
activity positively regulates neuronal antioxidant defense. We validated this hypothesis 
in mammalian neurons, finding that JNK activity regulates the expression of the 
antioxidant gene Srxn-1, in a c-Jun dependent manner. We describe a conserved 
µDGDSWLYH¶ UROH IRU QHXURQDO -1. LQ WKH PDLQWHQDQFH RI UHGR[ homeostasis that is 
relevant to several neurodegenerative diseases. 
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Introduction  
Active neurons generate reactive oxygen species (ROS) predominantly as a by-
product of mitochondrial respiration. ROS levels are neutralized by constitutive and 
adaptive reductive mechanisms operating in neurons and glia, including the 
glutathione system [1-3]. In this manner, the amplitude and temporal dynamics of the 
ROS signal are controlled, damage is limited and transient ROS signals can be 
interpreted in part to support the growth and plasticity of neurons [4, 5]. A physiological 
level of ROS has been demonstrated to regulate a range of nervous system 
processes, including neuronal development, synaptic plasticity, and neural circuit 
tuning [5-7]. 
 
In many neurodegenerative disorders the reductive capacity of neurons is 
overwhelmed, contributing to disease progression [4, 8]. These damaging levels of 
ROS, termed oxidative stress, overwhelm neuronal antioxidant defenses. A central 
component of the neuronal response to ROS is the activation of c-Jun N-terminal 
kinase, JNK. ROS have been shown to activate JNK-AP-1 signalling [9] which 
regulates neuronal growth and plasticity [10-13]. In Drosophila models, excessive 
ROS driving increases in synaptic growth are seen in both activity generated 
excitotoxicity and lysosomal storage disease [5, 12, 14]. Similar changes in synaptic 
structure can be induced directly by application of oxidants such as paraquat [12] or 
diethylmaleate (DEM) [5], or through genetic activation of JNK via manipulation of the 
JNKK hemipterous [15] (hep) or the JNKKK Wallenda [11] (wnd), upstream activators 
of JNK.  
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Whether JNK activation by ROS in neurons is protective or degenerative is unknown. 
Recent evidence indicates JNK-AP-1 activity can prevent degeneration of injured 
axons [16] while JNK inhibition prevents neuronal loss after injury by promoting AKT 
signaling [17]. 
 
We recently found that knockdown of enzymes involved in antioxidant defense, 
superoxide dismutase and catalase, reshapes neuronal morphology at the Drosophila 
larval neuromuscular junction (NMJ) [5]. Similarly, mis-expressing antioxidant 
enzymes to manipulate levels of individual ROS species has profound effects on 
synaptic and dendritic growth and arborisation [5, 12]. This suggests that plasticity at 
the synapse is finely tuned to the level of ROS. Given that JNK is known to regulate 
synaptic plasticity in response to ROS and that knockdown of antioxidant genes can 
change synapse structure, we hypothesized that JNK-induced structural changes in 
neurons are mediated in part by an antioxidant response.  
 
To understand if JNK activity regulates antioxidant responses in neurons, we 
monitored ROS levels in Drosophila with mutations in highwire (hiw) and puckered 
(pucE69). In hiw mutants, unrestrained wallenda (wnd) activity activates JNK and 
downstream AP-1 signaling to generate exuberant synaptic overgrowth [11, 18]. Puc 
encodes a dual specificity phosphatase, transcriptionally activated by AP-1 that 
counteracts JNK activity [19]. In both the hiw and pucE69/+ mutant backgrounds we 
identified enhanced antioxidant defenses and low levels of ROS. In hiw, this enhanced 
antioxidant defense can be reversed in neurons by down-regulating JNK-AP-1 
signaling.  Conversely, both pucE69/+ and hiw flies are resistant to chemically induced 
oxidative stress, while inhibition of JNK-AP-1 signaling increases ROS levels in wild 
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type neurons.  We show that in mammalian neurons exposed to oxidative stress, the 
JNK-AP-1 pathway coordinates the transcription and translation of the antioxidant 
gene Sulfiredoxin-1, which was localised predominantly in synaptic compartments. 
Our data indicates that activation of JNK in neurons drives antioxidant responses to 
shape synaptic plasticity. 
 
Results 
JNK Activity Drives Antioxidant Responses 
To quantify levels of ROS in Drosophila, we used the Amplex red assay for detection 
of hydrogen peroxide [20]. We have previously found that food containing 5mM and 
10mM DEM which depletes glutathione levels, is sufficient to induce an overgrowth at 
the larval NMJ [5], with 10mM concentrations being detrimental to survival (Fig S1, 6% 
of flies pupate). To understand whether DEM influences ROS levels in flies, we raised 
flies on food containing ethanol (vehicle) or 5mM DEM. Using Amplex red we found 
that wild type flies have an increased ROS burden when raised on food containing 
5mM DEM (Fig 1A). To investigate how JNK activity influences ROS levels under 
these conditions, we reared pucE69/+ and hiw mutants on the same food and found 
that both genotypes have significantly lower levels of ROS than wild type flies in 
vehicle-containing food.  Moreover, both genotypes failed to show an increase in ROS 
when reared on DEM-containing food (Fig 1A) suggesting that they are resistant to 
the oxidative stress generated by DEM.  
 
Given that both pucE69/+ and hiw mutants have lower levels of ROS than wild type flies 
and are resistant to chemically-induced oxidative stress, we hypothesized that if JNK 
activity could be reduced in neurons of these flies, then ROS levels would increase 
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back to wild type. To test this, we used hiw mutants and expressed dominant negative 
transgenes of jnk, wnd, ask1, jun and fos pan-neuronally using nSyb-Gal4 (Fig 1B). 
We found that pan-neuronal expression of these dominant negative transgenes 
increased ROS levels of hiw mutants back to wild type controls, except for ask1DN. 
This data indicates that manipulation of JNK, its upstream regulators and downstream 
targets, regulates ROS levels in neurons.  
 
To further evaluate the relationship between JNK activity and ROS levels, we 
investigated whether expression of dominant negative jnk, ask1 and wnd affects ROS 
levels in wild type flies. We found that expression of all dominant negative transgenes, 
pan-neuronally, significantly increases the ROS levels of wild type flies (Fig 1C). 
Indeed, the levels observed were similar to those observed when wild type flies are 
reared on food containing DEM.  
 
The elaborate synaptic morphology of hiw mutant flies has been extensively described 
[11] and is a consequence of activation of the JNK-AP-1 pathway. We therefore chose 
to evaluate the synaptic morphology of pucE69/+ neurons by analyzing the NMJ at 
Muscle 6/7, hemi-segment A3. Similar to hiw mutants, we found that pucE69/+ larvae 
have overgrown NMJ synapses (Fig 1D). DEM feeding also causes an overgrowth of 
the NMJ when compared to wild type flies reared on normal food. Feeding of DEM has 
no effect on the NMJ of pucE69/+ larvae, indicating that JNK activity alone is sufficient 
to change synaptic morphology, which correlates with an antioxidant response 
(decrease in ROS levels from Fig 1A). Furthermore, the DEM induced changes in 
synaptic plasticity in wild type flies, can be rescued when dominant negative 
transgenes of jun, fos and ask1 are expressed pre- and post-synaptically using 
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spinGAL4 (Figure 1D+E). Our observations in Drosophila show that JNK activity 
regulates synaptic morphology but also antioxidant responses. In pucE69/+ and hiw 
flies, JNK-AP-1 signalling generates an antioxidant response which lowers the total 
levels of ROS in flies and protects them from induced oxidative stress while also 
causing an increase in NMJ synapse size. In wild type flies, inducing oxidative stress 
changes synaptic morphology, generates a stress response and these responses can 
be regulated by JNK (Figure 1F). 
 
DEM induces oxidative stress in primary mammalian neurons. 
JNK activity in mammalian neurons is often associated with apoptosis and activated 
JNK is commonly used as a hallmark of cell death in neurodegenerative disease. 
Given that JNK-AP-1 signalling in the fly generates an antioxidant response and 
decreasing JNK activity in fly neurons increases ROS levels, we hypothesized that 
antioxidant responses in mammalian neurons would also be regulated by JNK-AP-1. 
Having previously validated the effects of DEM in the fly, we established a mammalian 
model of oxidative stress, using DEM to deplete cellular glutathione. We used this 
model to assay antioxidant responses after DEM treatment. We first characterized the 
effect of DEM on cellular GSH levels and ROS production in mature primary rat 
neurons, using a glutathione assay measuring total glutathione (oxidized and reduced 
forms). Figure S2 A shows that application of DEM to primary cortical neuronal 
cultures caused a concentration and time-dependent decrease in cellular glutathione. 
A 1 h and 4 h treatment of DEM at concentrations of 10 µM and 100 µM caused a 
rapid decrease in GSH (Fig S2A). Lower concentrations of 1 µM DEM reduced cellular 
GSH content with less severity. Given the extent of GSH depletion by DEM, we 
investigated whether DEM induces mitochondrial toxicity by monitoring WST-1 
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absorbance (Water Soluble Tetrazolium Salts) as a measure of mitochondrial stress. 
Compared to vehicle treated neurons, DEM induced a small but significant decrease 
in mitochondrial capacity, however this was much less than treatment with equivalent 
concentrations of paraquat (PQ) and rotenone (RT) (Fig S2B). To determine if DEM 
induces a ROS burden as it does in our fly model we measured H2O2 levels in neurons 
treated with DEM using Amplex red reagent. The Amplex red assay revealed that DEM 
(100 µM) significantly increased in H2O2 levels (Fig. S2C), after 24 hours compared to 
ethanol treated controls (Fig. S2C). DEM induced oxidative stress is significantly 
attenuated when neurons are pre-incubated with catalase. The duration and 
concentrations of DEM that we employed deplete glutathione and induce an increase 
in ROS with minimal toxicity to mitochondrial function.  
 
To model chronic oxidative stress, we treated neurons for longer time points (48 hr) 
with DEM (100µM) and found that DEM causes a retraction of the dendritic arbor. This 
effect is rescued when neurons are pre-incubated with Catalase (100nM, Fig S2D) 
and when the components that produce glutathione, the catalytic and modifying 
subunits of glutamate cysteine ligase (GCL), are transduced into neurons (Fig S3). 
 
Oxidative stress activates JNK-dependent SRXN-1 expression.  
JNK enzymes are key mediators of cellular responses to stress in neurons [21], 
including oxidative stress [22, 23], and alterations in JNK activity have previously been 
linked to changes in dendritic complexity [24]. Phosphorylation of threonine 183 and 
tyrosine 185 increase JNK activity [21]. To characterize the effectiveness of both DEM 
and the JNK inhibitor SU 3327 on regulating JNK phosphorylation and activation, we 
treated primary neurons with DEM (100µM, 1 hr) alone or in the presence of SU 3327 
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(700nM, 1 hr pre-treatment) and assayed JNK phosphorylation (Fig 2A). We found a 
significant increase in phospho-JNK/total JNK ratios when neurons were treated with 
DEM, which was significantly attenuated when JNK activity was blocked with SU 3327 
(Fig 2 A+B). 
 
Bicuculline, a competitive antagonist of GABAA Ȗ-aminobutyric acid) receptors, and 
4-aminopyridine, a voltage activated potassium blocker, are commonly used 
pharmacological tools that increase synaptic activity in cultures of cortical neurons 
[25]. These tools have shown that synaptic activity can upregulate neuronal 
antioxidant genes, in an ERK-AP-1 dependent manner. A putative antioxidant target 
gene of this signaling pathway, is Sulfiredoxin-1 (Srxn-1)[26]. To identify whether JNK-
AP-1 signalling could regulate neuronal antioxidant genes, we compared our 
experiments with neurons treated with Bicuculline (Bic, 50µM) and 4-Aminopyridine 
(4-AP, 500µM) as a positive control (Bic/4AP).  
 
Using DEM, we found that JNK activity regulates Srxn-1 transcription. DEM (10 µM) 
induced a 1.73-fold induction in Srxn-1 mRNA expression compared to the ethanol 
treated controls (Fig. 2C). When neurons were pre-treated with the JNK inhibitor SU 
3327 for 24 h, DEM failed to induce Srxn-1 mRNA. Similar to DEM treatment, 
increasing synaptic activity with Bic/4AP increased Srxn-1 mRNA (1.32-fold), however 
this induction was unaffected by JNK inhibition.  
 
Synaptic activity is known to induce expression of c-Fos, an AP-1 component. We 
determined whether oxidative stress also induced c-Fos transcription. Figure 2D 
shows that there was no change in c-Fos mRNA levels with DEM treatment whereas 
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Bic/4AP treatment robustly induced c-Fos transcription. Similar to activity-induced 
Srxn-1 induction, c-Fos induction by synaptic activity was unaffected by inhibition of 
JNK (Fig. 2D) suggesting that synaptic activity and oxidative stress recruit signaling 
pathways differentially to activate potentially divergent gene transcription responses.   
We next evaluated whether JNK activity regulates SRXN-1 protein expression. Figure 
2E shows that treatment of neurons with DEM (100 µM) rapidly increased SRXN-1 
protein expression within 30 min, with high levels detected at 4h as assessed by 
western blot using an antibody that we first validated by overexpressing human SRXN-
1 in HEK293T cells (Fig S4 A). DEM-induced SRXN-1 expression was attenuated 
when neurons were pre-treated with SU 3327 (700 nM, 1 h pre-incubation). As 
expected, and in agreement with previous work [26], synaptic activity also induced 
SRXN-1 expression after a 4 h treatment with Bic/4AP, which was attenuated when 
neurons were pre-treated for 1 h with the non-competitive NMDA receptor antagonist 
MK801 (10 µM) but was unaffected by JNK inhibition. Moreover, synaptic activity but 
not DEM, induced ERK activation (Figure 2E). Taken together, these data indicate that 
oxidative stress activates JNK to coordinate an antioxidant response in neurons, which 
is distinct from antioxidant responses coordinated by synaptic activity. 
 
JNK-c-Jun signaling regulates antioxidant responses. 
To identify the cellular mediators that co-ordinate SRXN-1 expression under 
conditions of synaptic activity or oxidative stress, we assessed the expression and 
interaction of putative AP-1 components under the two conditions. Cortical neurons 
were treated with Bic/4AP or DEM for 1 or 4 h and c-Fos or c-Jun immunofluorescence 
was quantified in NeuN positive neurons. In neurons treated with DEM (Figure 3A and 
3B) c-Fos immunofluorescence was found to decrease. In contrast, DEM induced a 
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significant increase in c-Jun immunofluorescence. As expected, in neurons stimulated 
with Bic/4AP for 1 or 4 h, both c-Fos and c-Jun immunofluorescence was found to 
increase (Fig S4, B+C). These data suggest that oxidative stress relies on Jun proteins 
to mount an antioxidant response in the absence of c-Fos. To further investigate the 
differential involvement of specific AP-1 components we immunoprecipitated c-Jun 
from cortical neurons treated for 1 h with either DEM or Bic/4AP and assessed its 
phosphorylation and association with c-Fos protein. While both DEM and Bic/4AP 
induce c-Jun expression and phosphorylation, c-Jun co-immunoprecipitated with c-
Fos following Bic/4AP-induced synaptic activity but not during oxidative stress 
mediated by DEM (Fig 3C).  In mammals, c-Jun can form heterodimers with other 
members of the Jun family to form the dimeric AP-1 transcription factor. To identify if 
c-Jun was associated with another Jun family member, we probed membranes for 
JunB and JunD and found no association between either protein with c-Jun in DEM-
treated neurons (Fig S4, D). To determine whether c-Jun alone is sufficient to induce 
SRXN-1 expression, lentiviral particles encoding human c-Jun (Fig 3D) were 
transduced into cortical neurons. Lentiviral c-Jun expression was sufficient to induce 
SRXN-1 expression in neurons (Fig 3E), however activation of Nuclear Factor 
Erythroid 2-related factor 2 (Nrf2) using the well characterized agonist TBHQ (10µM, 
16 h) had no effect on neuronal expression of SRXN-1. Taken together, these data 
suggest that oxidative stress activates JNK, which selectively recruits c-Jun to induce 
SRXN-1 expression in neurons (Fig 3F). 
 
SRXN-1 is localized at synaptic terminals and prevents dendrite loss.  
To understand how SRXN-1 contributes to neuronal antioxidant defenses we 
investigated SRXN-1 localisation in neurons. Having previously identified that chronic 
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treatment of cortical neurons with DEM causes a loss of dendrites, we transfected 
neurons with PSD95-GFP alone or in combination with a plasmid encoding N-terminal 
FLAG-tagged human SRXN-1 and treated cells with DEM (48 hours). We found that 
overexpression of SRXN-1 prevented dendrite loss caused by long-term treatment of 
DEM (Fig 4A). Interestingly, we also observed overexpressed SRXN-1 
immunoreactivity in distal dendrites and on closer examination found that 
overexpressed SRXN-1 was localised to dendrites and dendritic spines (Fig 4B). 
SRXN-1 co-localised with PSD-95-GFP, as indicated by white arrowheads in Figure 
4B.  
 
To further investigate the synaptic localization of SRXN-1, we assessed its distribution 
in subcellular fractions of mouse brain using the antibody validated in heterologous 
cells (Fig S4, A). Although characterized as a cytoplasmic enzyme [27], SRXN-1 was 
not observed in the synaptic supernatant fractions, but in the LP1 (synaptosomal) and 
LP2 (synaptic vesicle) membrane fractions. The efficacy of the fractionation was 
confirmed by enrichment of the transcription factor FOXO3a in supernatant fractions 
over the pellet fractions. The P2 fraction represents a crude synaptosomal fraction 
comprising microsomes and isolated pre- and post-synaptic nerve terminals. SRXN-1 
was most enriched in the LP1 fraction, indicative of synaptic membranes and small 
organelles, such as mitochondria. Immunoblotting for the alpha subunit of the 
mitochondrial F1 ATP synthase (ATP5A1) confirmed the presence of mitochondrial 
proteins in the LP1 fraction. SRXN-1 immunoreactivity was also present in the LP2 
fraction, which is enriched in synaptic vesicles (SV), as shown by an enrichment of the 
SV protein synapsin I (Fig 4C). JNK immunoreactivity was observed in all fractions, 
but was enriched in P2, LP1 and LP2, in-line with the distribution of SRXN-1. These 
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data suggest that SRXN-1 associates with synaptic membranes and is consistent with 
the co-localization with PSD95 we observed by fluorescence microscopy. Therefore, 
in neurons, antioxidant proteins such as SRXN-1 and sensors of oxidative stress such 
as JNK are located at synapses, placing them at functionally important sites to 
orchestrate the adaptive antioxidant response (Fig 4D).  
 
Discussion. 
Here we have uncovered a role for JNK signalling in the regulation of neuronal 
antioxidant capacity using Drosophila and mammalian neurons in culture. We and 
others have shown previously that JNK regulates changes in synaptic morphology 
independently of any stimuli [11] or in response to ROS [5, 12, 14]. We now show that 
JNK activation drives an antioxidant response, which shapes cellular reductive 
capacity and synaptic morphology.  
 
We show that Drosophila mutants that have enhanced JNK activity have low levels of 
ROS and furthermore, are resistant to chemically induced oxidative stress. These 
reduced ROS levels in mutant flies can be reinstated back to levels observed in wild 
type flies by inhibiting the JNK-AP-1 pathway. In addition to changes in ROS levels, 
we show that activation of the JNK-AP-1 pathway leads to overgrown synapses at the 
Drosophila NMJ suggesting that the status of JNK signalling has implications for 
structural synaptic plasticity. In mammaOLDQFRUWLFDOQHXURQVZHLGHQWLILHGDQµDGDSWLYH¶
JNK-dependent antioxidant response when neurons are challenged with oxidative 
VWUHVV7KLVDGDSWLYHUHVSRQVHUHOLHVRQ-1.¶VGRZQVWUHDPHIIHFWRUF-Jun, and results 
in increased abundance of the antioxidant protein SRXN-1. In contrast, JNK-
independent SRXN-1 expression is triggered with increased synaptic activity of 
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cortical neurons. We therefore implicate JNK signaling in the regulation of neuronal 
antioxidant defenses and identify distinct differences in neuronal responses to ROS 
generated in conditions of synaptic activity and oxidative stress. 
 
Constitutive JNK activation drives an antioxidant response in Drosophila.  
Genetic and pharmacological activation of JNK changes neuronal morphology and 
this structural change is dependent on AP-1 [15, 28]. JNK-AP-1 signalling has long 
been known to positively regulate growth and strength at the larval NMJ [15]. JNK has 
also been shown to mediate the effect of ROS generated during oxidative stress 
associated with excitotoxicity [14] and lysosomal storage disease [12]. Combined with 
reports that activation of the JNK pathway after neuronal injury coordinates a 
regenerative response [16] and that AP-1 signalling regulates dendrite growth during 
both development and during conditions of synaptic activity; JNK-AP-1 signalling has 
been demonstrated as a crucial regulator of neuronal homeostasis. Both pucE69/+ 
heterozygotes and hiw mutants, which have increased JNK activity, [11, 19] showed 
reduced total ROS levels and rendered flies resistant to chemically induced oxidative 
stress. The reduced ROS levels in pucE69/+ heterozygotes and hiw mutants flies could 
be reversed by inhibition of neuronal JNK-AP-1 suggesting that the altered ROS 
originates from neurons. The reduced total ROS levels, arising from  protective JNK 
signalling, in hiw mutants might explain the recently reported resistance of neurons in 
highwire null flies to the damaging effects of physical blows, which mimic traumatic 
brain injury [29]. 
 
A key question raised by our work is whether the JNK-dependent changes in synaptic 
morphology are driven by the increased antioxidant defenses. We have previously 
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identified DEM as a regulator of neuronal morphology at the NMJ [5] and here we 
show that this DEM-induced change in synaptic morphology is regulated by JNK. 
Furthermore, we show that pucE69/+ ODUYDH KDYH RYHUJURZQ 10-¶V ZKLFK DUH QRW
influenced by oxidative stress induced by DEM. Given that pucE69/+ and hiw larvae 
KDYH HOHYDWHG -1. DFWLYLW\ UHGXFHG 526 HODERUDWH 10-¶V DQG DUH UHVLVWDQW WR
chemically induced oxidative stress, our data suggests that changes in neuronal 
plasticity in these models is at least, in part, driven by an antioxidant response.  
 
JNK coordinates antioxidant responses in mammalian neurons.  
It is known that synaptic activity can regulate the expression of neuronal antioxidant 
genes [26]. Furthermore, we have recently shown that ROS generated from synaptic 
activity acts as a signaling molecule to regulate neuronal plasticity, in a PI3K/DJ-ȕ
dependent manner [5] implicating synaptic activity and ROS in the regulation of 
synaptic plasticity. What is currently unknown is how neurons recognize and respond 
to differences in physiological and pathological ROS. Our data shows that neurons 
recruit different signaling pathways to mediate ROS generated by synaptic activity or 
oxidative stress, but converge to regulate the same antioxidant gene, Srxn-1. 
 
Increasing synaptic activity activates ERK1/2 [30, 31] that can in turn phosphorylate 
AP-1 components [32, 33]. Consistent with this, we found that increasing synaptic 
activity using Bicuculline and 4-AP regulates Srxn-1 mRNA and protein expression 
[26]. Conversely, inducing oxidative stress in neurons with DEM did not affect ERK 
phosphorylation of AP-1 but did activate JNK and SRXN-1 expression. JNK inhibition 
abolished increased SRXN-1 in conditions of oxidative stress but not during synaptic 
activity. This suggests that neurons use distinct kinases to upregulate SRXN-1 
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expression in response to synaptic activity or oxidative stress. JNK activity can be 
regulated by cellular glutathione levels. In non-stressed cells, JNK is tethered to 
monomeric glutathione S-transferase Pi (GST-Pi) and increased H2O2 can trigger the 
detachment and oligomerization of GST-Pi, conjugating ROS to glutathione [34]. This 
suggests that JNK activity is tuned to the redox thresholds of the cell [35].  Both 
ERK1/2 and JNK kinases regulate AP-1 [21, 32], raising the possibility that the 
mechanisms converge at the level of this dimeric transcription factor. The AP-1 
heterodimer of c-Fos and c-Jun [36] is well characterized but the conditions driving 
differential heterodimer composition are not well understood. In our work, a notable 
difference between synaptic activity and oxidative stress conditions was the lack of c-
Fos transcriptional/translational induction by DEM and reduced dimerization with c-
Jun. This indicates that DEM-induced AP-1 activity and Srxn1 transcription is c-Fos 
independent (Fig 4 C+D). The mammalian AP-1 complex can contain Fos, Jun, Fra, 
and ATF components and multiple hetero- and homo-dimeric partners are capable of 
binding to AP-1 DNA binding sites [37, 38]. Our immunoprecipitation of c-Jun showed 
a clear association with c-Fos during conditions of increased synaptic activity, but this 
association was absent during conditions of oxidative stress. Moreover, total c-Jun 
increased during oxidative stress and we did not detect JunB or JunD in 
immunoprecipitates suggesting that c-Jun may homodimerise to generate an 
antioxidant response in neurons. Our data identify a clear divergence between 
physiological and stress-dependent signaling in neurons, where activation of JNK and 
lack of c-Fos defines the stress response.  
 
SRXN-1 is present at the synapse. 
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SRXN-1 is an oxidoreductase that reduces sulfinylated proteins such as 2-cys 
peroxiredoxins (PRDX), small redox sensitive proteins widely expressed in 
mammalian neurons [39]. Both cysteine residues in PRDX can undergo reversible 
hyper-oxidation by peroxides to form sulfinic acid (Cys-SO2H) [40]. Hyper-oxidation of 
PRDX proteins inactivates their peroxidase activity. This inactivation is known to occur 
in neurons where it can be seen to follow a circadian time course [41], and occur during 
glutamate induced excitotoxicity [42] in addition to oxidative stress conditions [43]. 
SRXN-1 catalyses the reduction of  Cys-SO2H in an ATP dependent manner, restoring 
PRDX activity [44]. Both PRDX and SRXN-1 are regulated by synaptic activity [26]. 
Our data indicate that the cellular levels of SRXN-1 can also be tuned by the 
intracellular concentration of GSH and H2O2 levels. 
 
We additionally show that SRXN-1 can be found at cellular locations that are 
particularly vulnerable to ROS - synaptic terminals and dendrites [45]. Overexpressed 
human SRXN-1 localised to dendrites and dendritic spines and endogenous SRXN-1 
protein was particularly enriched in synaptosomal membrane fractions. We also found 
that JNK kinases were present in synaptosomes. The localization of SRXN-1, a 
cytosolic protein, in a synaptic membrane fraction is intriguing. However, in non-
neuronal cells, SRXN-1 KDVEHHQUHSRUWHGWRWUDQVORFDWHIURPWKHF\WRVROWRDµKHDY\
PHPEUDQH¶ IUDFWLRQ HQriched in mitochondria in response to oxidative stress [46]. 
Mitochondrial SRXN-1 has a role in re-activation of oxidized peroxiredoxins [40, 47] 
and our data indicate that SRXN-1 might reside constitutively with neuronal 
mitochondria, consistent with a greater basal ROS burden in neurons.  
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Taken together, our data from both fly and mammalian models identify a fundamental 
conserved role of JNK signaling in regulating neuronal redox homeostasis through an 
adaptive antioxidant response. JNK signaling is activated specifically by oxidative 
stress and activates c-Jun containing AP-1 transcription factors independently of c-
Fos.  In this manner, JNK imparts mechanistic specificity to activate AP-1 under 
conditions that have relevance to a number of neurodegenerative diseases. 
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Materials and Methods 
 
Culture of neurons and cell lines. Timed-mated female Wistar rats (Charles River 
UK) (RRID:RGD_737929) were maintained in accordance with the UK Animals 
(Scientific Procedures) Act (1986). Cortices were dissected from postnatal day 1 
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(P1) mixed sex rat pups. Animals were euthanised using pentobarbital injection 
followed by cervical dislocation, according to Home Office guidelines. Cortical cell 
suspensions were obtained as previously described and cytosine arabinoside (AraC, 
2.4µM final concentration) was added to the growth medium at 1 DIV [48].  
 
Neurons were transfected at 12 days in vitro (DIV) with PSD95-GFP (a kind gift from 
David Bredt [49] and FLAG-tagged Human SRXN-1 (purchased from Origene: 
RC207654) for 5 h using Lipofectamine 2000 (11668019, Thermo Scientific). 
Experiments were performed in a defined culture medium (Transfection medium (TM) 
contains: 90 ml SGG; 114 mM NaCl, 26.1 mM NaHCO3, 5.3 mM KCl, 1 mM MgCl2, 2 
mM CaCl2, 10 mM HEPES, 1 mM glycine, 30mM glucose, 0.5 mM C3H3NaO3 and 10 
ml MEM (51200046, Thermo Scientific) supplemented with 100x ITS (1x final 
concentration; insulin/transferrin/selenium, 41400045, Thermo Scientific), penicillin 
(50 U/ml) and streptomycin (50 µg/ml)). After 24 h incubation in TM, cells were treated 
with DEM, bicuculline, catalase, paraquat, rotenone, 4-Aminopyridine or SU3327 at 
concentrations and durations stated in the figure legends.  
HEK293-FT (RRID:CVCL_6911, Thermo Scientific) cells were grown in DMEM 
containing 10% FBS. Cells were passaged and at 60% confluency, transfected with 
10 µg of either pCMV entry vector (empty) or pCMV Human SRXN-1. After 3 days, 
cells were lysed as described below. 
 
Lentiviral preparation. Lentiviruses were prepared using the 2nd generation system. 
Packaging plasmids were produced by the Trono lab (psPAX2 and pMD2.G were gifts 
from Didier Trono (Addgene plasmid #12260; http://n2t.net/addgene:12260; 
RRID:Addgene_12260 and Addgene plasmid #12259; http://n2t.net/addgene:12259; 
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RRID:Addgene_12259). pLenti c-Jun was created by cloning human c-Jun from 
PMIEG3-c-Jun (a gift from Alexander Dent (Addgene plasmid #40348)[50] using 
BAMHI and XHOI into pLenti-puro (a gift from Ie-Ming Shih (Addgene plasmid #39481; 
http://n2t.net/addgene:39481; RRID:Addgene_39481))[51]. Viral particles were 
generated and transduced as described previously [52].   
Hydrogen Peroxide Assay. Experiments were performed in phenol red free TM. TM 
containing 50 µM Amplex Red reagent and 0.1 U/ml HRP was added to neurons in 12 
well dishes (500µl per well) for 15 min after which cells were treated with different 
concentrations of DEM, or catalase. Fluorescence at 590 nm was measured 
periodically and compared against a H2O2 standard curve for quantification. For fly 
experiments, Amplex red reagent was made up in Hemolymph solution (HL3) 
containing NaCl (128mM), KCl (2mM), CaCl2.2H2O (1.8mM) MgCl2.6H2O (4mM), 
HEPES (5mM) and sucrose (35.5mM) at pH 7.2. Each fly was crushed in 250µl of 
Amplex red reagent using a pestle, vortexed and left at 25°C, in the dark for 90 
minutes. After 90 minutes, all samples were spun down for one minute and each 
biological replicate was read in duplicate. Only males were used for amplex red assays 
to avoid issues with dosage compensation.  
WST-1 Assay. After treatment, primary rat neurons were washed with TM and then 
incubated with phenol red free TM containing WST-1 reagent (Sigma, Cat# 
5015944001, 20 µl/ml) for 4 h at 37°C.  200 µl was transferred  to a 96 well plate and 
absorbance measured using a pODWHUHDGHU%0*)OXRVWDUȜ 0nm). 
Immunocytochemistry. Cells were washed with phosphate buffered saline (PBS) 
and fixed for 30 min at room temperature with 4% paraformaldehyde (containing 4% 
sucrose; Sigma). Cells were permeabilized in 0.5% NP40 in PBS for 5 min at room 
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temperature. All primary and secondary antibodies, dilutions and suppliers can be 
found in Table 1. Primary antibodies were incubated overnight at 4°C. Co rresponding 
Alexafluor secondary antibodies (1:500, Thermo Scientific) were incubated for 1 h at 
room temperature before mounting with Fluoromount (Sigma). 
 
Microscopy and Image Analysis. Images were collected on an inverted Zeiss 
microscope (880) with 20x or 63x Plan Neofluar objectives using Zeiss filter sets for 
DAPI and Alexa 488, 546 or 633. Images were taken at a resolution of 2048x2048 
pixels.  
 
Synaptosome Preparation. The subcellular fractionation of mouse brain was 
performed as previously described [53]. Briefly, seven mixed sex mouse forebrains 
were dissected and transferred into cold homogenization buffer (320 mM sucrose, 1 
mM EDTA, 5 mM Tris, pH 7.4, 4°C), homogenized in a glass Teflon homogenizer, and 
centrifuged in an SS-34 rotor (1000g, 10 min, 4°C). The sup ernatant (S1) was 
collected and the pellet re-suspended in 15 ml of homogenization buffer and 
centrifuged again (1000g for 10 min). S1 supernatants were combined, and pellets 
(P1) collected. S1 lysates were further centrifuged at 13000g for 20 min at 4°C. 
Supernatant (S2) was collected and the pellet (P2) re-suspended in 21 ml 
homogenization buffer. The P2 pellet was further centrifuged at 13000g for 20 min at 
4°C. P2 was re- VXVSHQGHGLQP0VXFURVHȝOIRUHEUDLQ), transferred into a 
glass-Teflon homogenizer with 9 volumes of ice-cold distilled water and immediately 
homogenized for 3 up/down strokes at 2000 rpm. Homogenates were incubated on 
ice for 30 min with 0.1 volume of 1 M HEPES-NaOH (pH 7.4) and centrifuged at 
25000g for 20 min at 4°C. Pellets (LP1, synaptosomal membranes) wer e collected 
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and the supernatant (LS1) further centrifuged in a 70 Ti rotor at 165,000g for 2 h at 
4°C. The resulting supernatant (LS2) was collected and the pellet (LP2, synaptic 
vesicles) re-suspended in 40 mM sucrose (2 ml). Protein concentration was assayed 
using Bradford reagent and 20 µg of each fraction was prepared in 1x Laemmli buffer 
for western blotting. 
 
Western Blotting. Cells were lysed in RIPA containing phosSTOP phosphatase 
inhibitors (4906845001, Roche) and complete EDTA-free protease inhibitors 
(04693132001, Roche) as previously described [54]. Lysates were run on Novex 
pre-cast mini gels (NuPAGE 4-12% Bis-Tris Gels, NP0322BOX, Thermo Scientific) 
in either 1 x MES or 1 x MOPS buffer. Antibodies used for immunoblotting are 
detailed in Table 1.  
 
Co-immunoprecipitation. Neurons in 10cm dishes were lysed as described. Lysates 
were incubated with primary antibodies for c-Jun at a 1:50 dilution and rotated 
overnight at 4°C. Lysates were incubated with 15µl (30µl bead slurry) Protein G, 
Sepharose (GE Healthcare, 17-0618-01) for 2 h at 4°C rotating. Samples were spun 
down, transferred to spin-x columns (Sigma, CLS8163-100EA), washed 3 times with 
lysis buffer and the beads finally incubated with 4 x Laemmli (containing 
mercaptoethanol) for 10 minutes, then eluted through the spin columns. Samples were 
further heated at 95°C for 5 minutes before western blotting. P roteins were detected 
using conformation specific antibodies (Cell Signaling, L27A9, mAb #3678) which 
prevent detection of heavy and light antibody chains. 
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Glutathione Assay. Total levels of glutathione were assayed using a colorimetric 
Glutathione Assay Kit (CS0260, Sigma). Briefly, at 14 DIV, primary neurons in 35 mm 
dishes were treated with DEM in transfection medium for 1, 4 and 24 h. Cells were 
then washed with PBS (4°C), lysed with 5% sulfosalicylic acid and sn ap frozen in liquid 
nitrogen. Lysates were then defrosted at 37°C, centrifuged at 10,000g  for 10 min and 
10 µl samples were used for the glutathione assay in accordance with the 
PDQXIDFWXUHU¶VLQVWUXFWLRQV 
 
Quantitative PCR. Real-time quantitative PCR on the resulting cDNA was performed 
using a Fast SYBR Green Master mix (Applied Biosystems, 4385612) and gene 
specific primers. Relative expression of genes was determined by the 2-ǻǻCT method 
and Gapdh for normalization. Primers used were: Gapdh forwDUG ¶-
AAACCCATCACCATCTTCCA-¶ DQG *DSGK UHYHUVH ¶- 
GTGGTTCACACCCATCACAA-¶ F-)RV IRUZDUG ¶- 
AGAATCCGAAGGGAAAGGAA-¶ DQG F-)RV UHYHUVH ¶- 
ATTGAGAAGAGGCAGGGTGA-¶6U[QIRUZDUG¶-GACGTCCTCTGGATCAAAG-
¶DQG6U[QUHYHUVH¶-GCAGGAATGGTCTCTCTCTG-¶ 
 
Drosophila stocks and husbandry. Drosophila were raised on 4-24® instant 
Drosophila medium (Carolina Biological Supply Company, USA) supplemented with a 
yeast sucrose solution (5% w/v inactivated yeast, 10% w/v sucrose in ddH2O, 
100g/500ml) and maintained at 25°C on a 12 h light:dark cycl e. Prior to mixing with 4-
24® instant media, vehicle (Ethanol) and DEM were added at the desired 
concentration (Ethanol 0.16%, DEM 0-10 mM). The following stocks were obtained 
from Bloomington Drosophila stock center: Canton-S (CS), w1118, UAS-bskK53R 
(#9311), UAS-fosDN (#7214), UAS-junDN (#7217), Act5C-Gal4 (Actin-Gal4), nsyb-Gal4. 
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UAS-ask1K618M (ask1DN) was a kind gift from Masayuki Miura [55]. UAS-wndDN (wndKD) 
and hiwND9 were kind gifts from Aaron DiAntonio [11, 56]. pucE69/TM6b flies were 
obtained from Alfonso Martinez-Arias [57]. SpinGal4/TM6b was obtained from 
Daisuke Yamamoto [58]. The JNK dominant negative (bskK53R)[59] and the highwire 
mutant (hiwND9) have been described previously [18]. All analyses were performed in 
males. hiwND9 females were crosses to Canton-S males to produce male hiwND9 
animals in an outcrossed background. For hiwND9 crosses with dominant negative 
transgenes, hiwND9; nsyb-Gal4 females were crossed with males carrying the UAS 
transgenes. All wild types were an outcross of Canton S to w1118. 
 
Survival Analysis. Hatched 1st instar larvae were collected and raised in standard 
food with different DEM concentrations (0 mM, 1mM, 5 mM and 10 mM). For each 
survival experiment, at least 2 vials, each containing 50 larvae, were maintained until 
fly eclosion. The number of eclosed flies was recorded. 
 
Immunohistochemistry and NMJ Analysis: Third instar wandering larvae were 
dissected, fixed, antibody stained, imaged and analysed as described previously [13]. 
All NMJ analysis was performed double-blind. Primary antibodies detailed in Table 1. 
Confocal microscopy was performed using a Zeiss LSM 880 on an Axio Observer.Z1 
invert confocal microscope (Zeiss). Z-VWDFNHGSURMHFWLRQVRI10-¶VDQG91&VZHUH
obtained using a Plan Neofluar 40x/0.75 NA oil objective. NMJ lengths were measured 
from stacked NMJ images using the NeuronJ plugin for ImageJ (National Institutes of 
Health) as described previously [13, 54]. 
 
Antibodies 
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Name Supplier Dilution Species RRID 
Anti- GFP Synaptic Systems 1:1000 Guinea Pig RRID:AB_11042617 
Anti- Synapsin 1 MERCK 1:1000 Rabbit RRID:AB_2200400 
Anti- GCLC SCBT 1:500 Mouse RRID:AB_2736837 
Anti- GCLM SCBT 1:500 Mouse RRID:AB_831789 
Anti- Phospho 
JNK 
Cell Signalling 
Technology 
1:1000 (WB) Mouse RRID:AB_2307321 
Anti SAPK/JNK 
Antibody 
Cell Signalling 
Technology 
1:1000 (WB) Rabbit RRID:AB_2250373 
Anti FOXO3a Cell Signalling 
Technology 
1:1000 (WB) Rabbit RRID:AB_2636990 
Anti- FLAG Sigma 1:1000 Mouse RRID:AB_259529 
Anti- FLAG Cell Signalling 
Technology 
1:1000 Rabbit RRID:AB_2217020 
Anti- c-Jun Cell Signalling 
Technology 
1:1000 (WB) Rabbit RRID:AB_2130165 
Anti- Phospho c-
Jun 
Cell Signalling 
Technology 
1:1000 (WB) Rabbit RRID:AB_2130162 
Anti- NeuN Millipore 1:2000 Guinea Pig RRID:AB_11205592 
Anti- c-Fos Cell Signalling 
Technology 
1:2000 (WB) Rabbit RRID:AB_2106617 
Anti- GAPDH  Millipore 1:10,000 (WB) Mouse RRID:AB_2107445 
Anti- JunB SCBT 1:1000 (WB) Mouse RRID:AB_2130023 
Anti- JunD SCBT 1:1000 (WB) Mouse RRID:AB_10650101 
Anti- SRXN-1  SCBT 1:250 (WB) Mouse RRID:AB_2286615 
Anti- ATP5A1 Proteintech 1:1000 (WB) Rabbit RRID:AB_2061761 
Anti- p44/42 
MAPK (Erk1/2) 
Cell Signalling 
Technology 
1:1000 (WB) Rabbit RRID:AB_330744 
Anti- Phospho-
p44/42 MAPK 
(Erk1/2) 
Cell Signalling 
Technology 
1:1000 (WB) Mouse RRID:AB_331768 
Drosophila NMJ 
Antibodies 
    
Anti- Horseradish 
peroxidase- Cy3 
(HRP-Cy3) 
Jackson 
ImmunoReasearch 
Labs 
1:200 Goat RRID:AB_2307391 
Anti- 
synaptotagmin 
(Anti-SYT91) 
Sweeney Lab 1:2000 Rabbit RRID:AB_2713991 
6HFRQGDU\$E¶V 
    
Gt anti Ms Alexa 
488 
Life Technologies 1:500 Goat RRID:AB_2576217 
Gt anti Rb Alexa 
546 
Life Technologies 1:500 Goat RRID:AB_10563566 
Gt anti Ms Alexa 
546 
Life Technologies 1:500 Goat RRID:AB_2534071 
Gt anti Rb Alexa 
488 
Life Technologies 1:500 Goat RRID:AB_2576217 
Peroxidase-
AffiniPure Goat 
Anti-Guinea Pig 
IgG (H+L) 
antibody 
Jackson 
ImmunoResearch 
Labs 
1:10,000 (WB) Goat RRID:AB_2337402 
Peroxidase-
AffiniPure Goat 
Anti-Rabbit IgG 
Jackson 
ImmunoResearch 
Labs 
1:10,000 (WB) Goat RRID:AB_2307391 
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Peroxidase-
AffiniPure Goat 
Anti-Mouse IgG 
(H + L) antibody 
Jackson 
ImmunoResearch 
Labs 
1:10,000 (WB) Goat RRID:AB_10015289 
Fluorescein 
(FITC) AffiniPure 
Goat Anti-Rabbit 
IgG (H+L) 
Jackson 
ImmunoResearch 
Labs 
1:200 Goat RRID:AB_2337972 
,3$E¶V 
    
Mouse Anti-rabbit 
IgG 
(Conformation 
Specific) (L27A9) 
mAb #3678 
Cell Signalling 
Technology 
1:5000 (WB) Mouse RRID:AB_1549606 
Anti-mouse IgG, 
HRP-linked 
Antibody #7076 
Cell Signalling 
Technology 
1:10,000 (WB) Horse RRID:AB_330924 
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Figure Legends 
Figure 1: JNK activity regulates neuronal antioxidant responses. A DEM induces 
oxidative stress in wild type flies but not puckered (pucE69/+) or highwire (hiw) mutants. 
Quantification of hydrogen peroxide levels (Amplex red fluorescence) in wild type, 
pucE69/+ or hiw mutant flies administered veh (0.16% ethanol) or DEM (5mM). B 
Quantification of hydrogen peroxide levels in hiw mutants and hiw mutants pan-
neuronally expressing dominant negative jnk (h; nSyb > bskR53K), wnd (h; nSyb > 
wndDN), ask1 (h; nSyb > ask1DN), jun (h; nSyb > junDN) and fos (h; nSyb > fosDN). C 
Quantification of hydrogen peroxide levels in wild type flies, pan-neuronally expressing 
dominant negative jnk (nSyb > bskR53K), wnd (nSyb > wndDN) and ask1 (nSyb > 
ask1DN). A-C Graphs show amplex red fluorescence values normalized to the average 
signal of wild type flies. Data are plotted as mean ± SEM (** p < 0.01; *** p < 0.001; 
one-way ANOVA; minimum 15 flies per genotype). D Representative micrographs 
showing synaptic overgrowth at the Drosophila third instar larval NMJ (Muscle 6/7, 
hemi-segment A3) in wild type, pucE69/+ mutants and wild type flies expressing 
dominant negative fos (fosDN), jun (junDN) and ask1 (ask1DN), reared on food containing 
ethanol or DEM. Scale bar = 30 µm. E Quantification of mean normalized bouton 
number from (D) genotypes. Data are plotted as mean ± SEM (*** p < 0.001; one-way 
$129$ PLQLPXP  10-¶V DQDO\VHG SHU JHQRW\SH. F Schematic showing the 
contribution of JNK to neuronal antioxidant stress responses in Drosophila. 
 
Figure 2: ROS induced JNK phosphorylation triggers neuronal antioxidant 
responses. A Representative western blot of neurons treated with Bicuculine (50 µM, 
Bic) and 4-Aminopyridine (500 µM, 4AP) to increase synaptic activity (Bic/4AP) or 
DEM (100µM) for 1 hour, to induce oxidative stress. JNK activity was inhibited by a 1 
hour pre-treatment with SU-3327 (SU, 700nM). B Quantification of total phospho-
JNK/pan-JNK ratios (* p < 0.05; ** p < 0.01; one-way ANOVA; n = 3 biological 
replicates). C+D The mRNA levels of Srxn-1 and c-Fos were determined using 
quantitative PCR (qPCR) and were normalized to Gapdh mRNA levels. mRNA levels 
are expressed relative to untreated controls and shown as means ± SEM (* p < 0.05; 
** p < 0.01; unpaired t-Test; n = 4 biological replicates) C Srxn-1 mRNA is induced by 
oxidative stress in a JNK dependent manner. D JNK signaling downstream of oxidative 
stress does not require c-Fos. E JNK regulates SRXN-1 expression under oxidative 
stress but not during synaptic activity. Representative western blot probed for SRXN-
1, Pan-JNK, phospho-JNK, Pan-ERK, phospho-ERK and GAPDH antibodies. 
Neurons were treated with Bic/4AP (50/500 µM) or DEM (100 µM) in the presence or 
absence of either the JNK inhibitor SU 3327 (700nM) or the NMDA receptor blocker 
MK801 (10µM) for 30 mins (lanes 2/4/6) or 4 h (lanes 3/5/7/8/9). 
 
Figure 3: JNK Recruits c-Jun for SRXN-1 expression. 
A+B Oxidative stress reduces c-Fos and increases c-Jun. Representative images 
showing c-Fos (top panels) and c-Jun (bottom panels) immunoreactivity in neurons 
left untreated (Control) or treated for  1 h with 100 µM DEM. Neurons were co-stained 
for the neuronal marker NeuN and nuclei were labelled with DAPI.  B Quantification of 
immunoreactivity in A, of neurons stimulated for 1 h or 4 h with 100 µM DEM. Data 
are plotted as mean ± SEM. Analysis represents NeuN positive neurons. c-Fos levels 
were assessed in 118 neurons and c-Jun immunoreactivity was quantified in 81 
neurons across 3 biological replicates (** p < 0.01; *** p < 0.001 one-way ANOVA 
IROORZHGE\D'XQQHWW¶VSRVW-hoc test). Scale bar = 25µm. C Representative western 
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blot of neuronal lysates immunoprecipitated with a c-Jun antibody in conditions of 
synaptic activity (Bic/4AP) or oxidative stress (DEM 100 µM) in the presence or 
absence the JNK inhibitor SU 3327 (700nM, 1 h). D Representative images of c-Jun 
immunofluorescence in HEK293T cells transduced with lentivirus encoding empty 
vector, or pLenti c-Jun. Scale bar = 25µm. E Western blot showing c-Jun, GAPDH and 
SRXN-1 levels in  neurons transduced with lentivirus containing empty vector (1) or c-
Jun (3) overnight, or treated with the Nrf2 agonist, tert-Butylhydroquinone (TBHQ, 
10µM, 4) overnight. HEK293T cells transduced with pLenti c-Jun (2) were run as a 
positive control. F A schematic demonstrating JNK and c-Jun dependent regulation of 
SRXN-1 during oxidative stress. 
 
Figure 4: SRXN-1 localises to synaptic terminals in rodent neurons and 
rescues DEM induced retraction.  
A SRXN-1 overexpression rescues DEM-induced dendritic retraction. Representative 
micrographs of mature neurons transfected with PSD95-GFP constructs alone (left 
panels) or in combination with Flag-tagged human SRXN-1 (right panels) ± 100µM 
DEM (48hr). Cells stained with anti-GFP (green), anti SRXN-1, (Flag antibody, red) 
and nuclear staining with DAPI (blue). Scale bar = 100 µm. B Overexpressed human 
SRXN-1 co-localises with PSD95-GFP in dendritic spines. Representative images 
show an overlay of GFP and Flag immunofluorescence. Magnified images of dendritic 
spines outlined in white boxes (PSD95-GFP+SRXN-1, scale bar = 5 µm). C  
Endogenous SRXN-1 protein is present at synapses. Representative western blot of 
synaptosome fractions prepared from mouse brain probed with antibodies for the 
nuclear protein FOXO3a, the pre-synaptic marker synapsin 1 (Syn1), the 
mitochondrial protein ATP5A1, JNK and SRXN-1 as indicated. D Schematic 
representation of likely signaling pathways mediating Srxn-1 transcriptional induction 
in response to synaptic activity and oxidative stress.  
 
Supplementary Figure Legends 
 
Figure S1. Effects of DEM on NMJ bouton number and survival in Drosophila. 
DEM (0 mM, 1 mM, 5 mM and 10 mM) was added to standard food and NMJ bouton 
number quantified. NMJ bouton number increases as DEM concentrations increase. 
(left y-axis, bars). Survival significantly decreases as DEM concentrations increase 
(right y-axis, red line). Data plotted as means ± SEM analysed using one-way ANOVA 
ZLWKD'XQQHWW¶VSRVWKRFS 
 
Fig S2: DEM depletes glutathione and induces oxidative stress. 
A. Total glutathione content in mature neurons treated with DEM at the indicated time 
and concentration. Total glutathione content is relative to ethanol treated controls and 
data are shown as means ± SEM (** p < 0.01; *** p < 0.001, using two-way ANOVA 
IROORZHG E\ D 'XQQHWW¶V post-hoc test; n = 3 biological replicates). B Mitochondrial 
toxicity was assessed using WST-1 assays in neurons treated with DEM, paraquat 
(PQ) and rotenone (RT) at the indicated concentrations, for 24 hours. WST-1 turnover 
is normalized to ethanol treated controls (Veh) and shown as means ± SEM (***p < 
0.001; one-way ANOVA; n = 3 biological replicates). C H2O2 production was monitored 
using Amplex red reagent. Neurons were treated with DEM and fluorescence 
measured after 24 hours. Catalase (100 nM) was added to neuronal cultures 15 min 
before DEM treatment. Data represents means ± SEM analysed using one-way 
ANOVA (*** p < 0.001, n = 3 biological replicates). Amplex red fluorescence is shown 
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as a percentage of vehicle (0.1% ethanol) treated controls. D Prolonged oxidative 
stress causes dendritic loss. Representative micrographs of neurons transfected with 
PSD95-GFP and treated, with either 0.1 % ethanol (control) or the indicated 
concentrations of DEM (100µM) +/- Catalase (100nM) for 48 h. Scale bar = 50 µm. 
 
Fig S3. DEM induced dendritic loss is rescued by GSH overexpression. A-D 
Mature neurons transfected either with a PSD95-GFP expression plasmid alone (top 
panels) or PSD-95GFP along with plasmids expressing the catalytic (GCLC) and 
modifying (GCLM) subunits of Glutamate Cysteine Ligase (bottom panels). Cells were 
incubated with either vehicle (0.1% ethanol) or DEM (100 µM) for 48 h (scale bar = 
100 µm). Insets show anti-GFP (green), anti-GCLC (red) and nuclei (blue). 
Fig S4. Synaptic activity induced c-Fos and c-Jun. A Representative western blot 
of protein samples from HEK293T cells transfected with a FLAG-tagged Human 
SRXN-1 expression vector and probed with anti-SRXN-1 mouse monoclonal antibody 
(top panel, SI Appendix, Table 1) or GAPDH antibody (bottom panel). B Synaptic 
activity induces c-Fos and c-Jun. Representative images showing c-Fos and c-Jun 
immunoreactivity in neurons left untreated (Control) or treated for 1 h or 4 h with 
Bicuculine (50 µM, Bic) and 4-Aminopyridine (500 µM, 4AP). Neurons were co-stained 
for the neuronal marker NeuN and nuclei were labelled with DAPI. Scale bar = 20µm. 
C Graphs showing c-Fos (left) and c-Jun (right) levels in neurons treated for 1 h or 4 
h with Bic/4AP. Data are plotted as mean ± SEM. Analysis represents NeuN positive 
neurons and c-Fos levels were assessed in 135 neurons across 3 biological replicates 
(*** p < 0.001 one-ZD\ $129$ IROORZHG E\ D 'XQQHWW¶V SRVW-hoc test). c-Jun 
immunofluorescence was assessed in 78 neurons across 3 biological replicates (*** p 
< 0.001 one-way ANO9$IROORZHGE\D'XQQHWW¶VSRVW-hoc test). CTCF = corrected 
total cell fluorescence analysis. D Representative immunoprecipitation of c-Jun in 
conditions of increased synaptic activity (Bic/4AP, 1 h) and oxidative stress (DEM, 100 
µM, 1 h) and western blot showing levels of JunB (upper panel) and JunD (lower 
panel).  
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